Physician

Alberto Antonio Franco-Akel, M.D.

According to 2025 Medicare claims, Alberto Franco-Akel, M.D. (NPI: 1194080317) practices endocrinology in the Watertown-Fort Drum, NY market, with the plurality of this provider's patient population coming from Jefferson, NY. This provider's primary affiliated billing organization is MEDICAL HEALTH 360 PLLC (NPI: 1497374359; TIN: 842358887) and primary practice location at 13601-4034. Franco-Akel is affiliated with the HHC ACO Inc (ACO ID: A1675), participating under the MSSP model.

Franco-Akel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 93 traditional Medicare patients, billed 321 HCPCS/CPT codes, and received $26,700 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 452 prescription claims across 57 beneficiaries totaling $174,118 in drug costs, led by Trulicity (Dulaglutide). 2019 DME data shows 11 claims. Open Payments data shows 7 records totaling $241. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,166 to $26,700. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $88,666 and ending at $174,118. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	77	136	$8,166
2017	102	177	$9,185
2018	76	169	$10,395
2019	53	93	$5,454
2020	44	70	$5,138
2021	40	60	$4,564
2022	80	183	$15,680
2023	114	477	$37,277
2024	93	321	$26,700

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	456	$88,666
2016	157	1,265	$146,225
2017	226	2,461	$302,063
2018	85	456	$109,805
2019	63	435	$64,833
2020	61	565	$119,910
2021	63	491	$116,802
2022	66	486	$135,256
2023	74	558	$231,769
2024	57	452	$174,118

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$130
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	32	34	$130
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	39	40	$102
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	35	98	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	17	25	$66
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	29	72	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	30	1,481	$45,097
Jardiance	Empagliflozin	24	1,620	$30,445
Ozempic	Semaglutide	26	890	$27,098
Farxiga	Dapagliflozin Propanediol	24	1,080	$18,814
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	1,095	$4,378

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$241	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alberto Antonio Franco-Akel, M.D.?

Tedicare shows public-source Medicare data for Alberto Antonio Franco-Akel, M.D. (NPI 1194080317), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alberto Antonio Franco-Akel, M.D. have ACO affiliation data?

Alberto Antonio Franco-Akel, M.D. is shown with ACO affiliation data for HHC ACO Inc (MSSP, ACO ID A1675).

What billing organization is linked to Alberto Antonio Franco-Akel, M.D.?

Alberto Antonio Franco-Akel, M.D. is linked to MEDICAL HEALTH 360 PLLC (billing NPI 1497374359) in the available physician profile data.

Does Alberto Antonio Franco-Akel, M.D. have Open Payments data?

Alberto Antonio Franco-Akel, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.